Vertex Pharmaceuticals Incorporated

URI: https://gptkb.org/entity/Vertex_Pharmaceuticals_Incorporated
GPTKB entity
Properties (37)
Predicate Object
gptkbp:instanceOf biotechnology company
gptkbp:acquisition gptkb:Concert_Pharmaceuticals
gptkb:Semma_Therapeutics
Exonics Therapeutics
gptkbp:advertising gptkb:Michael_A._McCarthy
gptkbp:CEO Reshma Kewalramani
gptkbp:clinicalTrials multiple ongoing
gptkbp:employees 3,000+
gptkbp:focus cystic fibrosis
gptkbp:founded 1989
gptkbp:founder gptkb:Joshua_Boger
gptkbp:headCoach gptkb:Michael_A._McCarthy
gptkb:Ira_C._Shapiro
gptkb:David_Altshuler
gptkb:Kathy_A._McCarthy
gptkb:Megan_A._McCarthy
gptkb:David_A._Hyman
James A. McGowan
gptkbp:headOfMarketing gptkb:Ira_C._Shapiro
James A. McGowan
gptkbp:headquarters gptkb:Boston,_Massachusetts
https://www.w3.org/2000/01/rdf-schema#label Vertex Pharmaceuticals Incorporated
gptkbp:insuranceAccepted gptkb:David_A._Hyman
gptkbp:localGovernment gptkb:Ira_C._Shapiro
gptkbp:market $60 billion (2023)
gptkbp:partnerships gptkb:AstraZeneca
gptkb:Moderna
gptkb:CRISPR_Therapeutics
gptkbp:philanthropy gptkb:Vertex_Foundation
gptkbp:products Kalydeco
Orkambi
Symdeko
Trikafta
gptkbp:researchFocus gene editing
gptkbp:revenue $6.2 billion (2022)
gptkbp:stockSymbol VRTX
gptkbp:tradedOn gptkb:NASDAQ